Last update 01 Nov 2024

RDX-002(Response Pharmaceuticals)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Mechanism
MTTP inhibitors(Microsomal triglyceride transfer protein inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypercholesterolemiaPhase 2
US
27 Sep 2024
HypertriglyceridemiaPhase 2
US
27 Sep 2024
ObesityPhase 2
US
27 Sep 2024
Weight GainPhase 2
US
27 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Biospace
ManualManual
Phase 1
24
Olanzapine + RDX-002
(eokyzdvvho) = udotrlrnim szaxcmmcmp (ltvutkjjeq )
Met
Positive
23 Apr 2024
Phase 1
-
RDX-002+Olanzapine
qhclmruwxv(fkiqyvwzna) = While full results are being analyzed, RDX-002 was generally well tolerated, and the study met its primary objective. xvczaxgobj (xrhducgxpb )
Met
Positive
17 Aug 2023
Olanzapine
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free